4//SEC Filing
Aviragen Therapeutics, Inc. 4
Accession 0001437749-16-031866
$VXRTCIK 0000072444operating
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:06 PM ET
Size
5.1 KB
Accession
0001437749-16-031866
Insider Transaction Report
Form 4
PLUMB RUSSELL H
DirectorCEO & President
Transactions
- Award
Stock Option (Right to Buy)
2016-05-12$1.50/sh+20,000$30,000→ 20,000 totalExercise: $1.50From: 2017-05-12Exp: 2026-05-12→ Common Stock (20,000 underlying)
Documents
Issuer
Aviragen Therapeutics, Inc.
CIK 0000072444
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000072444
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 5:06 PM ET
- Size
- 5.1 KB